India's benchmark indexes are likely to open little changed on Tuesday, after logging their best day in more than four years ...

Pharma stocks lit up Dalal Street on Tuesday as President Donald Trumps remarks on drug pricing sent mixed signals to global ...

Pharma stocks rise amid market drop due to limited impact from US pricing order. Discover more on what fuels this trend.

The sudden focus on pharmaceutical shares is due to a new executive order signed by US President Donald Trump on Monday.

Pharma stocks faced a downturn after US President Donald Trump revealed plans to slash drug prices. Sun Pharmaceuticals and ...

Indian Pharma stocks were on a strong uptrend today, with the Nifty Pharma index rising by 1.19% in intraday trade.

Pharma stocks were trading higher on May 13 after better-than-feared Donald Trump’s executive order on pharma last night.

On May 13, 2025, the domestic markets witnessed a sharp decline, with the BSE Sensex dropping 1.55 per cent to close at ...

Information technology and pharma sector, Tata Steel Ltd., and Hindalco Ltd. were among the top companies on brokerages' ...

The BSE Sensex witnessed sharp profit-booking in Tuesday’s session, dragged down by heavyweight IT stocks. The index declined ...

For the year so far, FIIs have been net sellers of shares worth Rs 1.25 lakh crore, while DIIs have net bought Rs 2.27 lakh ...

Indian stock markets saw notable declines on Tuesday due to profit-booking following Monday's surge, driven by eased Indo-Pak ...